Sight Sciences SGHT
NASDAQ SGHT
$8.26 +0.11 (+1.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Sight Sciences (SGHT) Income from Continuing Operations (2020 - 2026)

Sight Sciences (SGHT) posted quarterly Income from Continuing Operations of 12980000.0 for Q1 2026, up 8.29% year-over-year from 11985837.68 in Q1 2025, and down 211.87% quarter-over-quarter from 4162000.0 in Q4 2025.

Sight Sciences (SGHT) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Sight Sciences' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 12980000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 8.29% year-over-year to 12980000.0; the TTM figure through Mar 2026 stood at 37252000.0 (up 24.58% YoY), while the FY2025 annual figure was 38426000.0, up 25.4% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 12980000.0, down from 4162000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 4162000.0 in Q4 2025, with the low at 23843000.0 in Q2 2022.
  • The 5-year median for Income from Continuing Operations is 13035000.0 (2023), against an average of 14394235.29.
  • The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations sank 90.06% in 2022, then soared 64.87% in 2025.
  • Sight Sciences' Income from Continuing Operations stood at 16907000.0 in 2022, then surged by 36.77% to 10691000.0 in 2023, then declined by 10.8% to 11846000.0 in 2024, then jumped by 64.87% to 4162000.0 in 2025, then slumped by 211.87% to 12980000.0 in 2026.
  • Business Quant data shows SGHT's Income from Continuing Operations at 12980000.0 in Q1 2026, 4162000.0 in Q4 2025, and 8169000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 928.00 Mn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 1.28 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 905.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 241.40 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 1.04 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 201.00 Mn
10 Sight Sciences 449.13 Mn 369.37 Mn 21.37 Mn -4.45 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.45 Mn
Mar 31, 2026 -12.98 Mn
Dec 31, 2025 -4.16 Mn
Sep 30, 2025 -8.17 Mn
Jun 30, 2025 -11.94 Mn
Mar 31, 2025 -14.15 Mn
Dec 31, 2024 -11.85 Mn
Sep 30, 2024 -11.07 Mn
Jun 30, 2024 -12.33 Mn
Mar 31, 2024 -16.27 Mn
Dec 31, 2023 -10.69 Mn
Sep 30, 2023 -13.04 Mn
Jun 30, 2023 -14.75 Mn
Mar 31, 2023 -17.07 Mn
Dec 31, 2022 -16.91 Mn
Sep 30, 2022 -22.23 Mn
Jun 30, 2022 -23.84 Mn
Mar 31, 2022 -23.26 Mn
Dec 31, 2021 -15.94 Mn
Sep 30, 2021 -17.17 Mn